Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer’s disease
IntroductionThe role of the chemokine CX3CL1 in the processes of aging and Alzheimer’s disease (AD) pathogenesis is well-established. This study aims to evaluate the diagnostic potential of urinary CX3CL1 levels in distinguishing between AD patients, those experiencing amnestic mild cognitive impair...
Saved in:
Main Authors: | Yali Xu, Jie Zhang, Ying-Ying Shen, Wei-Wei Li, Bin Li, Hai-Ping Cheng, Gui-Hua Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2025.1501762/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An EEG-based framework for automated discrimination of conversion to Alzheimer’s disease in patients with amnestic mild cognitive impairment: an 18-month longitudinal study
by: Yingfeng Ge, et al.
Published: (2025-01-01) -
Clinical evidence of acupuncture for amnestic mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials
by: Guangyao Lin, et al.
Published: (2025-03-01) -
Discovery of the microbiota-gut-brain axis mechanisms of acupuncture for amnestic mild cognitive impairment based on multi-omics analyses: A pilot study
by: Zi-Han Yin, et al.
Published: (2025-03-01) -
Study of Brain Default Network Changes in Patients with Amnestic Mild Cognitive Impairment Based on rs-fMRI
by: HU Saiqin, et al.
Published: (2023-02-01) -
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer
by: Stefanie Seitz, et al.
Published: (2025-02-01)